FDA Warns California OTC Drugmaker for Defective Products

Drug Industry Daily
A A
The FDA issued a warning letter to Thibiant International for producing defective OTC drugs at its Newbury Park, California manufacturing facility.

To View This Article:

Login

Subscribe To Drug Industry Daily